TSC22D1 Antibody (YA8558)

(Synonyms: Ptg-2; TGFB1I4; TSC22)

TSC22D1 Antibody (YA8558) is a Mouse-derived and non-conjugated IgG2a monoclonal antibody, targeting to TSC22D1.

For research use only. We do not sell to patients.
  • Host:

    Mouse

  • Isotype:

    IgG2a

  • Application:

    IHC-P, FC

  • Reactivity :

    Human, Mouse, Rat

  • Formulation:

    Spplied in PBS (pH 7.3) containing 1% BSA, 50% glycerol and 0.02% sodium azide.

  • Conjugation:
    Non-conjugated

Applications

Application
IHC-P Info
IHC-P: Immunohistochemistry-Paraffin
FC Info
FC: Flow Cytometry
Dilution Ratio 1:150-500 1:100

Product Details

Description

TSC22D1 Antibody (YA8558) is a Mouse-derived and non-conjugated IgG2a monoclonal antibody, targeting to TSC22D1.

  • Host Mouse
  • Clonality Monoclonal
  • Species Reactivity
    Human, Mouse, Rat
  • Calculated Molecular Weight Predicted band size: 15.5 kDa
Immunogen

Full length human recombinant protein of human TSC22D1 produced in HEK293T cell.

Sensitivity

Endogenous

Purification

Affinity purified

Conjugation

Non-conjugated

Modification

Unmodified

Isotype

IgG2a

Product Properties

  • Appearance

    Liquid

  • Formulation

    Spplied in PBS (pH 7.3) containing 1% BSA, 50% glycerol and 0.02% sodium azide.

  • Storage & Stability

    Stored at -20°C for 1 year. Avoid repeated freeze / thaw cycles.

  • Shipping

    Shipping with blue ice.

Background

  • Function

    TSC22D1 transcriptional repressor. Acts on the C-type natriuretic peptide (CNP) promoter. Acts to promote CASP3-mediated apoptosis. Positively regulates TGF-beta signaling by interacting with SMAD7 which inhibits binding of SMAD7 to TGFBR1, preventing recruitment of SMURF ubiquitin ligases to TGFBR1 and inhibiting SMURF-mediated ubiquitination and degradation of TGFBR1. Contributes to enhancement of TGF-beta signaling by binding to and modulating the transcription activator activity of SMAD4. Promotes TGF-beta-induced transcription of COL1A2; via its interaction with TFE3 at E-boxes in the gene proximal promoter. Plays a role in the repression of hematopoietic precursor cell growth. Promotes IL2 deprivation-induced apoptosis in T-lymphocytes, via repression of TSC22D3/GILZ transcription and activation of the caspase cascade |May act to negatively regulate TGFB3 signaling and thereby inhibit cell death in mammary gland cells|Positively regulates cell death in response to TGFB3 during mammary gland involution[1][2][3][4][5][6].

  • Subcellular Localization

    Cytoplasm,Nucleus,Cell membrane,Cytoplasm,Nucleus,Mitochondrion,Cytoplasm,Nucleus,Mitochondrion,Cytoplasm,Nucleus

  • Expression


    Tissue_Specificity: Ubiquitously expressed in adult tissues (PubMed:26752201, PubMed:8651929). Expressed in the postmitotic epithelial compartment at the top of intestinal mucosal villi (PubMed:12468551)
    Induction: Induced by cytokines including TGFB1 in aortic endothelial cells

  • Isoforms & Post-Translational Modification

    Q15714 has 5 isomers: Q15714-1: 109677 Da (predicted); Q15714-2: 15680 Da (predicted); Q15714-3: 59863 Da (predicted); Q15714-4: 58859 Da (predicted); Q15714-5: 9369 Da (predicted).

  • Subunit

    Forms homodimers (PubMed:10488076)

  • SwissProt ID

    Q15714

  • Synonyms

    Ptg-2; TGFB1I4; TSC22

TSC22D1 Antibody (YA8558) Related Classifications

MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00